Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
10/30/2001 | US6310212 4-substituted quinoline derivatives |
10/30/2001 | US6310211 8-hydroxy-7-substituted quinolines as anti-viral agents |
10/30/2001 | US6310202 Nitric oxide carriers based on polyazamacrocycle complexes |
10/30/2001 | US6310095 Inhibitors of protein isoprenyl transferases |
10/30/2001 | US6310079 Non-steroidal antiinflammatory agents |
10/30/2001 | US6310076 Dihydropyridines and new uses thereof |
10/30/2001 | US6310067 Urocanic acid derivatives |
10/30/2001 | US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
10/30/2001 | US6310059 Constrained fused ring derivatives of piperidine or piperazine linked to hydrophobic substituents which enhance calcium channel blocking activity; combinatorial libraries for drug screening |
10/30/2001 | US6310050 Therapeutic use of compounds with β3-agonist activity |
10/30/2001 | CA2216160C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
10/30/2001 | CA2113189C Diaminic compounds, preparation, use and intermediates |
10/30/2001 | CA2074723C Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity |
10/30/2001 | CA2048931C Carbamoyl-1-(pyridinylalkyl)-1h-indoles, indolines and related analogs |
10/30/2001 | CA2048027C 3-arylindole and 3-arylindazole derivatives |
10/25/2001 | WO2001079204A1 Phenyl substituted 4-hydroxy tetrahydropyridone |
10/25/2001 | WO2001079198A1 Pyrazoles for inhibiting protein kinase |
10/25/2001 | WO2001079195A2 Pyridine and pyrazine derivatives as thrombin inhibitors |
10/25/2001 | WO2001079194A1 Method for obtaining derivatives of [[(pyridil substituted)methyl]thio]benzimidazol |
10/25/2001 | WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation' |
10/25/2001 | WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase |
10/25/2001 | WO2001079179A2 Dihydro-2h-naphthalene-1-one inhibitors of ras farnesyl transferase |
10/25/2001 | WO2001079177A1 Cyclic diaza compounds for treating neurodegenerative disorders |
10/25/2001 | WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
10/25/2001 | WO2001079167A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
10/25/2001 | WO2001078734A1 Methods of treatment |
10/25/2001 | WO2001078723A1 Compounds and methods |
10/25/2001 | WO2001078697A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
10/25/2001 | WO2001078648A2 6-methylnicotinamide derivatives as antiviral agents |
10/25/2001 | WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
10/25/2001 | WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
10/25/2001 | WO2001019798A3 Inhibitors of factor xa |
10/25/2001 | WO2000061541A8 Pharmaceutical compounds |
10/25/2001 | US20010034451 Treatment for central degenerative disorders, brain power disorders, depressions, and for prophylaxis of cerebral circulatory disorders |
10/25/2001 | US20010034448 New compounds, their preparation and use |
10/25/2001 | US20010034447 N-(5-tert-butyl-2-methoxyphenyl)-n'-(4-(1-oxoisoindolin-5-ylox y)penyl)urea as anticarcinogenic agents |
10/25/2001 | US20010034445 Compounds such as 3-(3,4-Dihydro-8-((((6-amino2-pyridinyl) methyl)methylamino)carbonyl)-1-methyl-2,5-dioxo-1h-1,4-benzo diazepine)4-propanoic acid used as antiinflammatories, anticarcinogenics, and to treat angiogenesis, restenosis, etc |
10/25/2001 | US20010034444 Treating schizophrenia, depression, and Parkinson's disease; side effect reduction |
10/25/2001 | US20010034362 Pyrrolidine derivatives for vision and memory disorders |
10/25/2001 | US20010034352 Cardiovascular disorders |
10/25/2001 | US20010034351 A quinazoline compound |
10/25/2001 | US20010034348 Nitric oxide synthase inhibitor; nervous system disorders |
10/25/2001 | US20010034343 Crohn's diseas, antiulcer agents, asthma, emesis |
10/25/2001 | US20010034051 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes |
10/25/2001 | DE10020517A1 New 13-halo or cyano-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease |
10/25/2001 | DE10019145A1 New phenyl substituted 4-hydroxy-tetrahydropyridone derivatives useful for control of animal pests and as herbicides |
10/25/2001 | CA2406475A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
10/25/2001 | CA2406032A1 Dihydro-2h-naphthalene-1-one inhibitors of ras farnesyl transferase |
10/25/2001 | CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase |
10/25/2001 | CA2405233A1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
10/25/2001 | CA2398446A1 Pyrazoles for inhibiting protein kinases |
10/24/2001 | EP1148053A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient |
10/24/2001 | EP1148050A1 Retroviral protease inhibitors |
10/24/2001 | EP1147112A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
10/24/2001 | EP1147104A1 Aromatic heterocyclic compounds as antiinflammatory agents |
10/24/2001 | EP1147103A1 Phenantrhridine-n-oxides with pde-iv inhibiting activity |
10/24/2001 | EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
10/24/2001 | EP1147094A1 Non-peptide glp-1 agonists |
10/24/2001 | EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents |
10/24/2001 | EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity |
10/24/2001 | EP1147088A1 6-arylphenanthridines with pde-iv inhibiting activity |
10/24/2001 | EP1147084A1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
10/24/2001 | EP1147083A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
10/24/2001 | EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response |
10/24/2001 | EP1146871A1 Antidepressant heterocyclic compounds |
10/24/2001 | EP1045843A4 Inhibitors of farnesyl-protein transferase |
10/24/2001 | EP0970050B1 Process for the preparation of 10,11-dihydro-5h-dibenzo a,d]cyclohept-5-enes and derivatives thereof |
10/24/2001 | EP0892796B1 Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
10/24/2001 | EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
10/24/2001 | EP0835246B1 Aromatic compounds and pharmaceutical compositions containing them |
10/24/2001 | EP0755393B1 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4- 3-(1-methylethylamino)-2-pyridinyl]piperazine |
10/24/2001 | EP0731801B1 Substituted aminoalkylaminopyridines |
10/24/2001 | EP0629621B1 Crystal of quinolonecarboxylic acid derivative hydrate |
10/24/2001 | CN1319100A Isoquinoline derivatives with angiogenesis inhibiting activity |
10/24/2001 | CN1319096A Quinazoline derivatives and pharmaceutical applications thereof |
10/24/2001 | CN1319094A Imidazolyl derivatives |
10/24/2001 | CN1319092A Benzamide derivatives and their use as cytokine inhibitors |
10/24/2001 | CN1319090A Novel substuted indolimones, their preparation process and use as medicine |
10/24/2001 | CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
10/23/2001 | US6307087 Ligands for metals and improved metal-catalyzed processes based thereon |
10/23/2001 | US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
10/23/2001 | US6307053 Process for preparing imidacloprid |
10/23/2001 | US6307052 Acid-addition salts of optically active piperidine compound and process for producing the same |
10/23/2001 | US6307048 Enantioselective alkylation of tricyclic compounds |
10/23/2001 | US6306950 Improving the heat resistance of the title resin by including titanium dioxide having a zinc content of <0.1%; also includes an impact modifier, a stabilizer and a lubricant; pipes for conveying hot water; extrusion; discoloration inhibition |
10/23/2001 | US6306892 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use |
10/23/2001 | US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
10/23/2001 | US6306884 Benzamidine derivatives and their use as anti-coagulants |
10/23/2001 | US6306883 Compounds |
10/23/2001 | US6306880 Triazole antifungal agent |
10/23/2001 | US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals. |
10/23/2001 | US6306864 Cerebral deficits subsequent to or resulting from cardiac bypass surgery and grafting, stroke, cerebral ischemia, spinal cord trauma, head trauma |
10/23/2001 | US6306860 2,5-pyridinedicarboxylic acid derivatives |
10/23/2001 | US6306853 Dicarboxylic ester derivatives of dihydropyridine compounds |
10/23/2001 | US6306850 Chlorocyclopropyl-3-(2-chlorophenyl)-2-hydroxypropyl)2,4-dihyd ro-(1,2,4)-triazole-3-thione as fungicides |
10/23/2001 | US6306181 For dyeing human hair |
10/23/2001 | CA2085570C Pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them |
10/23/2001 | CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
10/18/2001 | WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
10/18/2001 | WO2001077102A1 Macrocyclic chelants for metallopharmaceuticals |